About SMPL Life Sciences Private Limited
Data last updated:
SMPL Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 December 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC229383. Its GSTIN is 09AAQCS7546E1ZT (Uttar Pradesh). The company holds 6 GST registrations, all of them active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Gaurav Sabharwal and Meenu Sabharwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1003 – 1005 Vishal Tower District Centre Janak Puri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2025, the company reported a revenue of ₹194.66 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.11 Cr (net margin 0.6%) and EBITDA of ₹5 Cr (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 24% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹82.74 Cr and satisfied charges of ₹9.5 Cr on record. Court records list 2 cases involving the company, including 2 filed against it. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹29 Lakh; the latest was in March 2018. Its 10 peer companies in the Pharma industry (Pharma Retail and Distribution) are compared by revenue, 5 larger and 5 smaller; the largest is Umang Cure Private Limited with revenue of ₹203.3 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website smplgroup.org.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address1003 – 1005 Vishal Tower District Centre Janak Puri, New Delhi, Delhi, India – 110058
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of SMPL Life Sciences Private Limited
The main business activity of SMPL Life Sciences is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of SMPL Life Sciences Private Limited FY 2024 filings available
SMPL Life Sciences Private Limited reported revenue of ₹194.66 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of SMPL Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 6% growth in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of SMPL Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.11 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of SMPL Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of SMPL Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of SMPL Life Sciences Private Limited
SMPL Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Umang Cure Private Limited | ₹203.3 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | New Delhi, Delhi, India |
| Thulasi Pharmacies India Private Limited | ₹202.66 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Coimbatore, Tamil Nadu, India |
| Vasu Vaccines & Speciality Drugs Private Limited | ₹198.66 Cr (FY 2023) | •••• | •••• | 12.0% | •••• | Hyderabad, Telangana, India |
| Pers Enterprises Private Limited | ₹197.75 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Chennai, Tamil Nadu, India |
| Zippin Pharma Private Limited | ₹194.99 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Mumbai, Maharashtra, India |
| SMPL Life Sciences Private Limited this company | ₹194.66 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Sood Medicine Traders Private Limited | ₹194.03 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Punjab, India |
| Yogiram Distributors Private Limited | ₹193.7 Cr (FY 2025) | •••• | •••• | 44.0% | •••• | Cuddalore, Tamil Nadu, India |
| Chimanlal Sons Medicare Products Private Limited | ₹193.43 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Mumbai, Maharashtra, India |
| Livanova India Private Limited | ₹192.91 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Dlf Qe, Haryana, India |
| Anm Pharma Private Limited | ₹190.81 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below SMPL Life Sciences by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of SMPL Life Sciences Private Limited
SMPL Life Sciences Private Limited is audited by J.S. SACHDEVA & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| J.S. SACHDEVA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of SMPL Life Sciences Private Limited
SMPL Life Sciences has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Sabharwal | Director | 28 Dec 2011 | 14 Years 9 Months | Current |
| Meenu Sabharwal | Director | 28 Dec 2011 | 14 Years 9 Months | Current |
| Sarika Sabharwal Also directs: Sabharwal Medicos LLP, Alma Mater Agencies Private Limited | Director | 28 Dec 2011 | 14 Years 9 Months | Current |
Ownership and Shareholding of SMPL Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of SMPL Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 2025 | Others | ₹50 Lakh | Open |
| 06 Sep 2024 | Axis Bank Limited | ₹1 Cr | Open |
| 08 Apr 2024 | Others | ₹5 Cr | Open |
| 07 Mar 2023 | Others | ₹4 Cr | Open |
| 29 Sep 2021 | Hdfc Bank Limited | ₹1.84 Cr | Open |
Total charge records: 9 View all charges
Deals & Funding of SMPL Life Sciences Private Limited
SMPL Life Sciences Private Limited has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹29 Lakh; the latest was in March 2018.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2013 | Funding round | ₹29 Lakh | Investors: 4 individuals |
Full deal history
All 4 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of SMPL Life Sciences Private Limited
SMPL Life Sciences Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed. Status as checked between 30 Sep 2026 and 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Faridabad, Haryana | Cheque dishonour complaint | Filed against the company by Glensmith Labs Private Limited | Disposed |
| District court, South West, Delhi | Civil suit | Filed against the company by State | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at SMPL Life Sciences Private Limited
SMPL Life Sciences Private Limited has a workforce of 30 employees as of Mar 24, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on SMPL Life Sciences Private Limited
SMPL Life Sciences Private Limited has 5 board changes on record since 2011: 3 appointments and 2 cessations. The latest: Gaurav Sabharwal ceased to be Director on 16 Jun 2025.
12 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for SMPL Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by SMPL Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of SMPL Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of SMPL Life Sciences Private Limited
SMPL Life Sciences has 6 GST registrations: 6 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAQCS7546E1ZT | Uttar Pradesh | Active | 01 Jul 2017 |
| 27AAQCS7546E1ZV | Maharashtra | Active | 01 Jul 2017 |
| 06AAQCS7546E1ZZ | Haryana | Active | 04 Jul 2019 |
| 29AAQCS7546E1ZR | Karnataka | Active | 30 Sep 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of SMPL Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SMPL Life Sciences Private Limited
SMPL Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 December 2011 (15+ years old) and is registered under CIN U24232DL2011PTC229383.
SMPL Life Sciences reported revenue of ₹194.66 Cr for FY 2025 (up 6% YoY).
SMPL Life Sciences has 3 current directors:
- Gaurav Sabharwal - Director
- Meenu Sabharwal - Director
- Sarika Sabharwal - Director
SMPL Life Sciences reported a net profit of ₹1.11 Cr (net margin 0.6%) and EBITDA of ₹5 Cr (EBITDA margin 2.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of SMPL Life Sciences is 26% over three years and 24% over five years. In the latest year (FY 2025) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of SMPL Life Sciences is 09AAQCS7546E1ZT, registered in Uttar Pradesh. The company has 6 GST registrations in all, of which 6 are active. Other active GSTINs include 27AAQCS7546E1ZV (Maharashtra), 06AAQCS7546E1ZZ (Haryana), 29AAQCS7546E1ZR (Karnataka).
The CIN (Corporate Identification Number) of SMPL Life Sciences is U24232DL2011PTC229383. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SMPL Life Sciences has 2 court cases on record: 2 filed against it.
SMPL Life Sciences was incorporated on 28 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
SMPL Life Sciences has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹29 Lakh; the latest was in March 2018.
The peers of SMPL Life Sciences by revenue are Umang Cure Private Limited, Thulasi Pharmacies India Private Limited, Vasu Vaccines & Speciality Drugs Private Limited, Pers Enterprises Private Limited, Zippin Pharma Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).